Position in GSK
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,255,334
-$175,828 QoQ
Shares Held
62,101
-0.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#192
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cardinal Capital Management holds $99,250,544 across 9 Drug Manufacturers - General names. GSK ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,505 | $31,790,894 | |
| 2 | JNJ |
Johnson & Johnson
|
114,813 | $29,159,057 | |
| 3 | MRK |
Merck & Co., Inc.
|
96,235 | $12,366,197 | |
| 4 | NVS |
Novartis AG
|
49,670 | $7,784,282 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
105,075 | $6,054,421 | |
| 6 | SNY |
Sanofi
|
80,450 | $3,431,997 | |
| 7 | GSK |
GSK plc
This page
|
62,101 | $3,255,334 | |
| 8 | PFE |
Pfizer Inc
|
124,537 | $2,998,850 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,255,334 | 62,101 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $3,431,162 | 62,170 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $3,027,925 | 61,744 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,654,037 | 61,493 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,310,374 | 60,166 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $2,269,079 | 58,572 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $1,972,652 | 58,328 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $2,304,487 | 56,372 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $2,139,214 | 55,564 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $2,322,439 | 54,174 | Shares | Sole | 2024-07-12 | |
| 2023-12-31 | $1,847,144 | 49,842 | Shares | Sole | 2024-07-12 | |
| 2023-09-30 | $1,798,580 | 49,616 | Shares | Sole | 2024-07-12 | |
| 2023-06-30 | $1,734,527 | 48,668 | Shares | Sole | 2024-07-12 | |
| 2023-03-31 | $2,679,992 | 75,323 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $1,114,781 | 31,724 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $900,911 | 30,612 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,706,786 | 39,977 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,693,821 | 39,646 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $1,646,003 | 38,055 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,427,437 | 38,089 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $1,884,113 | 48,242 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $825,202 | 23,574 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $789,363 | 21,870 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $770,944 | 20,883 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $861,547 | 21,535 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $802,450 | 21,593 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||